HomeFileStructural heart disease

Structural heart disease

View Category

Structural heart disease

Cost-Effectiveness of TAVR in Intermediate-Risk Patients

Prior economic analyses had shown that transcatheter aortic valve replacement (TAVR) is cost-effective (which does not mean...
solaci -
Learn More
Coronary disease

The 10 Most Read Articles of January

1- These Were the Most Relevant Article of 2018 in the Field of Coronary Diseases Read the best...
solaci -
Learn More
Structural heart disease

NOTION and UK TAVI Report Good Long-Term Outcomes

Both studies followed beyond 5 years patients with severe aortic stenosis who had undergone transcatheter aortic valve replacement...
solaci -
Learn More
Structural heart disease

Un Underestimated Symptom of Aortic Stenosis

For the first time, this long term observational study on a large cohort of contemporary patients with...
solaci -
Learn More
Structural heart disease

How long should we wait with asymptomatic aortic stenosis and preserved LVEF?

Courtesy of Dr. Carlos Fava. Asymptomatic severe aortic stenosis with preserved ventricular function is challenging. At present, it...
solaci -
Learn More
Mitral valve

Good Outcomes for MitraClip “Off Label”

Courtesy of Dr. Carlos Fava. Mitral regurgitation is the most frequent type of valve disease, accounting for >6% of...
solaci -
Learn More
Peripheral vascular disease

Are Aortic Stenosis and Kidney Dysfunction Associated?

Courtesy of Dr. Carlos Fava. Aortic stenosis happens in 2.8% of patients over 75, and is even more...
solaci -
Learn More
Structural heart disease

Anticoagulation Plays a Controversial Role in TAVR

Men gender, kidney failure and atrial fibrillation are the factors that most affect 3-year mortality after transcatheter...
solaci -
Learn More